How Retinol Works: The Science of Cell Renewal

What exactly happens when retinol enters your skin?

When retinol is applied to the skin, it undergoes a tightly regulated two-step enzymatic conversion. First, retinol oxidises to retinaldehyde via retinol dehydrogenase enzymes present in keratinocytes. Second, retinaldehyde is irreversibly oxidised to all-trans retinoic acid by retinaldehyde dehydrogenase (RALDH) enzymes. It is this all-trans retinoic acid — the active metabolite — that binds directly to nuclear receptors inside skin cells and triggers gene transcription. No other over-the-counter retinoid achieves this without requiring the skin's own enzymatic machinery to complete the conversion sequence.

This conversion cascade is the molecular basis for retinol's uniquely balanced profile. Because the skin must process retinol into its active form, delivery is inherently time-released. The rate-limiting step — oxidation to retinaldehyde — ensures that a flood of retinoic acid does not hit the receptors all at once. This explains both the efficacy and the tolerability gap between retinol and prescription retinoids like tretinoin, which bypass this step entirely and bind receptors immediately upon absorption.

How does retinoic acid signal skin cells to behave differently?

Once formed, all-trans retinoic acid enters the nucleus of fibroblasts and keratinocytes and binds to heterodimers of retinoic acid receptors (RARs) and retinoid X receptors (RXRs). These receptor complexes latch onto specific DNA sequences called retinoic acid response elements (RAREs) in the promoter regions of hundreds of genes. Binding activates transcription of genes that code for structural proteins, growth factors, and enzymes — while simultaneously suppressing genes that drive collagen breakdown and abnormal keratinisation.

Which genes are switched on?

The most clinically significant upregulated genes include COL1A1 and COL1A2, which encode type I collagen — the predominant structural protein in human dermis. Transcription of elastin and fibrillin genes also increases. Meanwhile, matrix metalloproteinase (MMP) genes — particularly MMP-1 (collagenase) and MMP-3 (stromelysin) — are downregulated. These enzymes are responsible for degrading the extracellular matrix after UV exposure. By suppressing MMPs, retinoic acid shifts the balance away from collagen destruction and toward net deposition.

What about epidermal turnover?

In the epidermis, retinoic acid upregulates heparin-binding EGF-like growth factor, which stimulates basal keratinocyte proliferation. It also accelerates the shedding of corneocytes by loosening desmosomal connections in the stratum corneum. The net effect is a compressed cell cycle: basal cells divide faster, migrate upward more rapidly, and desquamate sooner. This explains the visible smoothing of rough texture and the initial flaking some users experience during the first weeks of use.

Why does retinoid concentration matter for different skin types?

Concentration influences the number of RAR receptors occupied, which determines the amplitude of the transcriptional response. Low concentrations — 0.1% to 0.3% retinol — produce submaximal receptor occupancy, sufficient for gradual improvement in fine lines and texture over 12 to 24 weeks. Higher concentrations — 0.5% to 1% — push receptor occupancy toward saturation, accelerating results but also increasing the probability of RAR-mediated irritation pathways, including cytokine release and stratum corneum barrier disruption.

For Hong Kong's subtropical climate, this dose-response relationship matters practically. High humidity levels — often exceeding 80% in summer — increase transepidermal water loss paradoxically when barrier function is compromised. Starting at a lower concentration and titrating upward allows the epidermis to adapt its lipid lamellae structure before exposure to heavier retinoid loads, reducing the sting and erythema that often derail consistency.

What is the retinoid conversion chain and why does each step exist?

The full retinoid metabolic pathway in human skin runs: retinyl palmitate → retinol → retinaldehyde → all-trans retinoic acid. Each step is catalysed by a different enzyme family, and each enzyme has different expression patterns across skin layers and between individuals. This stepped architecture is not arbitrary — it allows the cell to control exactly how much active retinoic acid is present at any given moment.

Retinyl palmitate: the storage form

Retinyl palmitate is the esterified storage form found in many over-the-counter products. It requires cleavage by esterases to release retinol. This extra step makes it the gentlest retinoid, but also the least potent. Studies using human skin biopsies show minimal gene expression changes compared to retinol at equivalent molar concentrations.

Retinaldehyde: the direct precursor

Retinaldehyde requires only one enzymatic step to reach retinoic acid. It binds antibacterial proteins in the skin and has a slightly more favourable irritation profile than retinol at comparable efficacy doses. However, it is chemically less stable in formulations and more expensive to stabilise, which limits its commercial availability in Hong Kong retail channels outside dermatologist-dispensed lines.

Hydroxypinacolone retinoate (HPR): the ester that bypasses conversion

HPR belongs to a newer class of retinoid esters that bind RAR receptors directly without requiring enzymatic conversion. Published crystallography data confirm that HPR docks into the retinoic acid binding pocket of RAR-γ — the predominant RAR subtype in human epidermis — with affinity comparable to all-trans retinoic acid. Because it skips the oxidative steps, HPR activates the same gene transcription cascade as retinoic acid but with significantly lower irritation potential. This makes it particularly relevant for humid climates where occluded sweat ducts under occlusive products can amplify irritant penetration.

How does retinol affect the dermal-epidermal junction?

The dermal-epidermal junction (DEJ) is a specialised basement membrane that anchors the epidermis to the dermis. With age and photodamage, this junction flattens — the interlocking rete ridges become shallower, reducing the surface area for nutrient exchange and mechanical adhesion. Retinoic acid upregulates laminin-5 and collagen IV, two key structural components of the basement membrane. Histological studies of retinoid-treated skin show partial restoration of rete ridge pattern after 12 months of use, which optically improves skin translucency by enhancing light reflection at the junction.

What role do retinoids play in melanogenesis?

Retinoic acid influences pigmentation through multiple mechanisms. It disperses melanin granules within keratinocytes, creating a more even distribution that visually reduces spot intensity. It also accelerates epidermal transit time, which increases the rate at which melanin-laden keratinocytes are shed from the surface. However, retinoids do not directly inhibit tyrosinase — the rate-limiting enzyme in melanin synthesis — which is why they pair effectively with ingredients like niacinamide that block melanosome transfer, or ascorbic acid that intervenes at the oxidation step.

Tranexamic acid and retinoids: complementary pathways

Tranexamic acid inhibits the plasminogen/plasmin system, reducing the release of inflammatory mediators that stimulate melanocytes. In Hong Kong, where post-inflammatory hyperpigmentation from acne is a leading dermatological concern — especially in skin types III and IV common among the local population — combining a retinoid with tranexamic acid addresses both the turnover deficit and the inflammatory trigger. Clinical trials using this combination have demonstrated faster clearance of post-acne marks than retinoid monotherapy.

How do peptides enhance retinoid outcomes without increasing irritation?

Retinoids and peptides operate on different but converging pathways. Retinoids work primarily through nuclear receptor activation and gene transcription. Peptides function as extracellular signalling molecules — matrikines — that bind to cell-surface receptors and stimulate collagen and elastin synthesis via growth factor pathways. Using them together targets collagen production from two angles: gene-level upregulation from retinoids, and receptor-level activation from peptides.

This dual mechanism is the basis behind formulations like the ageLOC Tru Face Peptide Retinol Complex, which layers multiple retinoid technologies with signalling peptides to broaden the collagen-stimulating signal without stacking retinoid concentrations into the irritant range. In a subtropical environment where barrier stress from heat and humidity is already elevated, combination strategies like this can sustain retinoid use through summer months when standalone high-strength retinol would traditionally be scaled back.

What happens during the 'retinisation' period?

The first four to six weeks of consistent retinoid use trigger an adaptive response known as retinisation. During this period, the stratum corneum undergoes accelerated compaction and the epidermis thickens overall — but barrier lipids lag behind. Ceramide synthesis temporarily decreases relative to the faster turnover rate, leaving transient gaps in the lipid lamellae. This produces the hallmark dryness, flaking, and sensitivity. By weeks eight to twelve, lamellar body secretion normalises and ceramide levels rebound, resulting in a stratum corneum that is more compact, more cohesive, and functionally superior to baseline.

Can you shorten the retinisation phase?

Clinical strategies to compress this window include short-contact application (washing off after 30 minutes), every-third-night initiation schedules, and concurrent use of barrier-repair moisturisers containing a 3:1:1 ratio of ceramides, cholesterol, and free fatty acids. Niacinamide applied in the same routine has also been shown to upregulate ceramide synthase and reduce transepidermal water loss during the retinisation phase.

Why do some retinoids degrade in sunlight and what does that mean for daytime use?

Retinol and retinaldehyde contain conjugated double bonds that absorb UV radiation in the 325-360 nm range. This absorption causes photoisomerisation and photodegradation, converting the retinoid into inactive oxidation products. This is why retinol is overwhelmingly formulated for night use. However, the degradation concern is primarily about the molecule losing efficacy, not about phototoxicity — retinol itself does not generate reactive oxygen species under UV exposure the way some other compounds do. The risk is that you apply an active that degrades before it can convert to retinoic acid.

HPR and photostability

Hydroxypinacolone retinoate demonstrates superior photostability compared to retinol. Its esterified structure shields the polyene chain from UV-induced isomerisation, which means formulations containing HPR can tolerate brief incidental sun exposure without the same degree of molecular degradation. This does not mean it can replace sunscreen — but it does reduce the pressure to be perfectly light-disciplined in a city as bright as Hong Kong.

How should Hong Kong skin types adjust retinoid usage seasonally?

Seasonal adjustment is standard dermatological practice in high-humidity climates. During summer months (May through September in Hong Kong), heat and moisture increase percutaneous absorption and amplify sensory irritation. Scaling back frequency — from nightly to every other night — while maintaining concentration often preserves adaptation better than switching to a lower percentage. In the cooler, drier winter months, absorption decreases, barrier lipids become more ordered, and frequency can safely increase. This seasonal rhythm synchronises retinoid intensification with the period of greatest natural barrier resilience.

What skin concerns respond fastest to retinoid treatment?

Response time varies by indication. Comedonal acne and rough texture improve earliest — often within four to six weeks — because these depend primarily on epidermal turnover acceleration and desquamation. Fine lines and post-inflammatory hyperpigmentation require dermal remodelling and typically show measurable improvement at eight to twelve weeks. Deep static wrinkles and significant photodamage demand the longest treatment duration, with plateau improvements seen at six to twelve months in clinical trials. The critical variable across all indications is consistency, since gene expression effects from retinoic acid are reversible and decay within days of discontinuation.

Frequently Asked Questions

Can I use retinol every night when I first start?

Beginning every third night for the first two weeks gives your stratum corneum time to upregulate ceramide production. Increasing to every second night for weeks three and four, then to nightly only if no persistent redness or stinging occurs, is the safest titration schedule.

Does retinol thin the skin over time?

Retinol thins the stratum corneum — the outer dead layer — making it more compact and translucent. At the same time, it thickens the living epidermis and dermis by stimulating keratinocyte proliferation and collagen deposition. Net skin thickness actually increases with long-term use.

Why does my skin look worse during the first weeks of retinol use?

Accelerated cell turnover brings microcomedones and clogged material to the surface faster than the skin can shed them smoothly. This temporary 'purging' phase typically resolves within four to six weeks as the follicular lining normalises and desquamation becomes more even.

Is it safe to use retinol in Hong Kong's summer humidity?

Yes, but frequency should be adjusted. High humidity increases chemical penetration, which can amplify irritation. Dropping to every other night and using a lightweight, non-occlusive moisturiser underneath helps maintain tolerance without losing the dermal benefits.

Can I layer retinol with exfoliating acids?

Layering retinol with AHAs or BHAs in the same routine significantly increases barrier disruption. If both are desired, they should be used on alternate nights, or acids should be applied in the morning while retinol stays in the evening routine.

How long before I see anti-ageing results from retinol?

Fine line softening typically becomes visible at eight to twelve weeks of consistent use. Maximal collagen remodelling requires six to twelve months. Results plateau but are maintained as long as application continues, since retinoid effects are reversible.

Does retinol help with acne scars or just active breakouts?

Retinol improves post-inflammatory hyperpigmentation and shallow atrophic scarring by accelerating epidermal turnover and stimulating dermal collagen. It does not directly fill deep ice-pick or boxcar scars, but it can improve their appearance by firming surrounding skin.

NuBest Skin is an Independent Nu Skin Brand Affiliate -- not produced or endorsed by Nu Skin Enterprises Inc.